EP. 1: Key Trials in Transplant-Ineligible NDMM
January 14th 2025Beth Faiman, PhD, CNP, discusses how to optimize treatment strategies for multiple myeloma patients by considering factors like transplant eligibility, risk stratification, and emerging clinical trial data from PERSEUS, MAIA, and CEPHEUS to guide decisions around initial therapy, maintenance approaches, and the use of novel drug combinations.